Multi-omics analysis of myricanol effects on gene expression and microRNA regulation

Extractor, Experiment

📗 Cite This Artifact

←

Home / Artifacts / Multi-omics analysis of myricanol effects on gene expression

🧫

Multi-omics analysis of myricanol effects on gene expression and microRNA regulation

active

experiment Created: 2026-04-10T22:46:31 By: experiment_extractor Quality: 88% ✓ SciDEX ID: experiment-exp-3b7faafc-4bd9-407f-ae87-8

🧫 Experiment Protocol Gene Expressionproposed

Related Entities

ACSL1, PPARγ, CYP7A1, SCD1, ACLY, SREBF1, CPT1A, ACC1, APOE4

▸Metadata

_origin	{'url': None, 'type': 'internal', 'tracked_at': '2026-04-10T22:46:31.354067'}
p_value	None
protocol	RNA sequencing for transcriptome analysis, metabolomics for metabolite profiling, pathway enrichment analysis for functional annotation
effect_size	None
sample_size	None
source_pmid	41520958
extracted_at	2026-04-10T15:46:31.270380
_schema_version	1
experiment_type	gene_expression
success_criteria	Significant differential expression of target genes, pathway enrichment in lipid metabolism, coordinated regulation of metabolic networks
expected_outcomes	Upregulation of beneficial metabolic genes, modulation of lipid metabolism pathways, altered microRNA expression profiles
statistical_methods	None

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

Incoming

293

Outgoing

0 supporting 0 contradicting 0 neutral

View full evidence profile →

🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

This artifact has no version history yet.

Linked Artifacts (336)

mentions📖APOE4 Lipid Metabolism Optimization80%

mentions📖SREBF1 Gene80%

mentions📖APOE4 Homozygous Astrocytes80%

mentions📖APOE4 and Alzheimer's Disease Risk80%

mentions📖SCD1 Protein80%

related📖SCD1 Protein72%

related📖APOE4 Homozygous Astrocytes72%

mentions📖RNA Metabolism Dysfunction in Corticobasal Syndrome70%

mentions📖RNA Therapeutics for Neurodegeneration Investment Landscape70%

mentions📖RNA Therapeutics: Investment Landscape Analysis70%

mentions📖RNA Interference (RNAi) Therapies for Neurodegeneration70%

mentions📖ACLY Inhibition Rescues Alpha-Synuclein Autophagy70%

mentions📖RNA-Targeted Therapeutics Investment Synthesis70%

mentions📖RNA-Based Therapeutics for Alzheimer's Disease70%

mentions📖RNA Metabolism Dysregulation in 4R-Tauopathies70%

mentions📖RNA Editing Therapeutics70%

mentions📖RNA Binding Fox-1 Homolog 1 (RBFOX1)70%

mentions📖RNA Metabolism Dysregulation in Alzheimer's Disease70%

mentions📖RNA Splicing Dysregulation in 4R-Tauopathies: A Comparative 70%

mentions📖RNA G-quadruplexes in Neurodegeneration70%

mentions📖RNA-Based Therapeutics for Neurodegenerative Diseases70%

mentions📖RNA Stability and Decay70%

mentions📖RNA Splicing in Neurodegeneration70%

mentions📖RNA-Targeted Therapies in Neurodegeneration70%

mentions📖RNA Metabolism in Alzheimer's Disease70%

mentions📖SCD1 Gene70%

mentions📖RNA Processing in Neurodegeneration70%

mentions📖RNA Targeting Therapy for Neurodegeneration70%

mentions📖RNA Splicing Defects in Neurodegeneration70%

mentions📖IFN-γ Protein70%

mentions📖APOE4 Lipid Homeostasis Modulator for Pre-Symptomatic Alzhei70%

mentions📖RNA Metabolism Dysregulation Pathway70%

mentions📖ACSL1 Protein — Acyl-CoA Synthetase Long Chain Family Member70%

mentions📖RNA Metabolism in Neurodegeneration70%

mentions📖APOE4 (Apolipoprotein E4)70%

mentions📖RNA-Targeting Therapies for Neurodegenerative Diseases70%

mentions📖RNA Toxicity Pathway70%

mentions📖RNA Granule Dysfunction in Neurodegeneration70%

mentions📖RNA Binding Fox-3 Homolog (NeuN) (RBFOX3)70%

mentions📖RNA Binding Fox-1 Homolog 2 (RBFOX2)70%

related📖RNA Toxicity Pathway63%

related📖RNA Editing Therapeutics63%

related📖IFN-γ Protein63%

related📖RNA Stability and Decay63%

related📖APOE4 (Apolipoprotein E4)63%

mentions📖Mechanisms60%

related📖Mechanisms54%

mentions📖omega-3-fatty-acid-signaling-neurodegeneration50%

mentions📖Prodromal Resilience Package for Genetically High-Risk Cohor50%

mentions📖Ketone Body Therapy for Neurodegenerative Diseases50%

mentions📖Anti-Herpetic Viral Therapy for Neurodegeneration Prevention50%

mentions📖Donanemab (Kisunla)50%

mentions📖Amyloid-beta Degradation Pathways50%

mentions📖Exercise and Physical Activity for Neuroprotection50%

mentions📖Circadian Entrainment Therapy for Neurodegeneration Preventi50%

mentions📖apoe-genotype-guided-prevention50%

mentions📖LX1001 Long-Term Follow-up (NCT05400330) - Gene Therapy for 50%

mentions📖APOE contributes to Alzheimer's disease by regulating b50%

mentions📖mTOR Signaling in Neurodegeneration50%

mentions📖Tau-Targeted Therapeutics50%

mentions📖Cholinergic Degeneration Pathway50%

mentions📖Neural Stem Cell Failure Hypothesis in Alzheimer's Dise50%

mentions📖pericyte-dysfunction50%

mentions📖Myelin Repair Therapies50%

mentions📖Ganglioside and Membrane Lipid Raft Dysfunction in 4R-Tauopa50%

mentions📖TYROBP/DAP12 Microglia Signaling Pathway in Alzheimer's50%

mentions📖Amyloid Clearance Mechanisms50%

mentions📖Advanced Computational Neuroscience and AI-Driven Drug Disco50%

mentions📖CBS/PSP Clinical Trials Guide50%

mentions📖Lecanemab (Leqembi)50%

mentions📖Senolytic Prevention Protocol for Neurodegeneration Risk Red50%

mentions📖Lewy Body Dementia50%

mentions📖Computational Pharmacology and AI-Driven Drug Combination Op50%

mentions📖BBB-Penetrant Antibody Engineering50%

mentions📖omega-3-fatty-acids-neurodegeneration50%

mentions📖ALZ-801 Phase 3 APOLLOE4 Extension Trial50%

mentions📖Anti-Amyloid Therapeutics50%

mentions📖Phosphorylated Tau 217 (p-tau217)50%

mentions📖Alzheimer's Disease Genetic Variants50%

mentions📖Anti-Amyloid Antibody Clinical Trials50%

mentions📖LX1001 Phase 1/2 Trial (NCT03634007) - Gene Therapy for APOE50%

mentions📖csf-pta18150%

mentions📖All Pages50%

mentions📖Aduhelm50%

mentions📖Prime Editing for Neurodegenerative Diseases50%

mentions📖Cell Types50%

mentions📖Section 113: Emerging Gene Therapy Approaches for CBS/PSP50%

mentions📖Neuroinflammation Targeting Therapies50%

mentions📖Advanced Immunotherapy Platforms for Tau50%

mentions📖Oligodendrocyte-Myelin Dysfunction Hypothesis in Parkinson&#50%

mentions📖Vascular Cognitive Impairment (VCI)50%

mentions📖Diagnostics50%

mentions📖Farnesoid X Receptor (FXR) Signaling in Neurodegeneration50%

mentions📖Cerebral Amyloid Angiopathy Pathway in Neurodegeneration50%

mentions📖Bepranemab (UCB0107)50%

mentions📖Section 148: Advanced Nutritional Biochemistry in CBS/PSP50%

mentions📖Sigma-1 Receptor Agonists in Neurodegenerative Disease50%

mentions📖Neurovascular Dysfunction in Alzheimer's Disease: Integ50%

mentions📖Section 107: CRISPR-Based Therapies in CBS/PSP50%

mentions📖CBS Parietal Cortical Degeneration50%

mentions📖Polygenic Risk Score Integration Panel for Alzheimer's 50%

mentions📖Microglial Cells — Cell Type Hierarchy50%

mentions📖APP→Amyloid-beta→Plaque→Alzheimer's Disease Causal Chai50%

mentions📖Blood-Brain Barrier Dysfunction in Vascular Cognitive Impair50%

mentions📖Section 216: Advanced Pharmacogenomics for CBS/PSP50%

mentions📖Adenine Base Editing of APOE4 to APOE3 for Alzheimer's 50%

mentions📖Complement System50%

mentions📖Hormone Neuroprotection in CBS/PSP50%

mentions📖APOE Genotyping for Neurodegenerative Disease Risk Assessmen50%

mentions📖Microglial Polarization50%

mentions📖Antibody Therapy for Neurodegenerative Diseases50%

mentions📖Axonal Transport Dysfunction Comparison Across Neurodegenera50%

mentions📖Cerebral Amyloid Angiopathy in Neurodegeneration50%

mentions📖autophagy-lysosomal-ad50%

mentions📖Mechanisms Dashboard50%

mentions📖section-198-advanced-precision-medicine-implementation-cbs-p50%

mentions📖CRISPR and Genome Editing Brain Delivery50%

mentions📖Metabolic Dysfunction in Alzheimer's Disease50%

mentions📖Cell-Based Immunotherapy for Neurodegenerative Diseases50%

mentions📖Microbiome-Guided Prevention Bundle for Neurodegeneration Ri50%

mentions📖TREM2-APOE Axis in Neurodegeneration50%

mentions📖Immunotherapy for Neurodegenerative Diseases50%

mentions📖Cerebral Amyloid Angiopathy: Mechanism and Neurodegeneration50%

mentions📖amyloid-cascade-pathway50%

mentions📖Metabolic Therapy for Neurodegeneration50%

mentions📖Splice-Modulating Therapies for Neurodegeneration50%

mentions📖Neuroinflammation in Alzheimer and Parkinson Disease50%

mentions📖CLU-Clusterin Amyloid Clearance Dysfunction AD Causal Chain50%

mentions📖ad-prevention-vs-treatment50%

mentions📖APOE2 (Apolipoprotein E2)50%

mentions📖SCD1 Gene50%

mentions📖iPSC-Derived Microglia50%

mentions📖TREM2 Agonists in Alzheimer Disease50%

mentions📖Enhanced Glymphatic Clearance Protocol50%

mentions📖Therapy Ideas50%

mentions📖APOE3 (Apolipoprotein E3)50%

mentions📖APOE Lipid Metabolism Pathway in Alzheimer's Disease50%

mentions📖AD-FTD Tau-TDP-43 Overlap: Mechanism Comparison50%

mentions📖omega-3-fatty-acids-parkinsons50%

mentions📖oxidative-stress-comparison50%

mentions📖CRISPR Gene Editing for Neurodegeneration50%

mentions📖LRP1-ApoE Signaling Cascade50%

mentions📖Exosome-Based Drug Delivery for CBS/PSP50%

mentions📖Tau Immunotherapies for Neurodegenerative Diseases50%

mentions📖Combination Biomarker Panels for Alzheimer's Disease50%

mentions📖Blood-Brain Barrier Breakdown as Primary Disease Driver50%

mentions📖Calcium Dysregulation in Alzheimer's Disease50%

mentions📖APOE contributes to Alzheimer's disease by regulating b50%

mentions📖Blood-Brain Barrier Breakdown in Neurodegeneration50%

mentions📖Lipid Dysregulation in Neurodegeneration50%

mentions📖lu-af8790850%

mentions📖Myelin Pathology Disease Comparison — AD/PD/ALS/FTD/HD50%

mentions📖Section 45: Neuroinflammation Imaging and PET Tracers in CBS50%

mentions📖Amyloid-beta Fibril Formation Pathway50%

mentions📖Synaptic Dysfunction in Alzheimer's Disease50%

mentions📖mRNA Therapy for Parkinson's Disease50%

mentions📖Chronic Traumatic Encephalopathy (CTE) Treatment50%

mentions📖biomarker-guided-therapy50%

mentions📖Companies50%

mentions📖Section 135: Telomere Biology and Anti-Aging Interventions i50%

mentions📖Lipid-Loaded Microglia (Foam Cells)50%

mentions📖section-186-crispr-base-editing-therapeutics-cbs-psp50%

mentions📖Brain Pericytes in Neurodegeneration50%

mentions📖Induced Pluripotent Stem Cell (iPSC) Disease Models50%

mentions📖Florbetapir (Amyvid) Amyloid PET Imaging50%

mentions📖Section 218: Advanced Nutritional Genomics and Personalized 50%

mentions📖SREBF1 Gene50%

mentions📖Inferior Colliculus Neurons in Auditory Processing50%

mentions📖CSF1R Inhibitors for Parkinson's Disease50%

mentions📖PPAR Signaling Pathway in Neurodegeneration50%

mentions📖Combination Therapy Approaches in Neurodegenerative Disease50%

mentions📖Glia-Neuron Crosstalk in Alzheimer's Disease50%

mentions📖pharmacogenomics-cbs-psp50%

mentions📖Small Molecule Drugs for Neurodegenerative Diseases50%

mentions📖Nanoparticle Brain Delivery Systems50%

mentions📖Vascular Cognitive Impairment Prevention Bundle for At-Risk 50%

mentions📖Aducanumab (Aduhelm)50%

mentions📖Accelerating Medicines Partnership Alzheimer's Disease 50%

mentions📖Gene Editing for Neurodegenerative Diseases50%

mentions📖Metabolic Dysfunction (Type 3 Diabetes) Hypothesis in Alzhei50%

mentions📖Researchers50%

mentions📖Pericyte Loss in Neurodegeneration50%

mentions📖Sex-Specific Mechanisms in Alzheimer's Disease50%

mentions📖Section 134: Advanced Lipidomics and Membrane Therapy in CBS50%

mentions📖Vascular Dementia Mechanisms — Overlap with Alzheimer's50%

mentions📖Promising Clinical Trials in Neurodegenerative Diseases50%

mentions📖Novel Therapy Index50%

mentions📖ABCA1→Cholesterol Efflux→APOE Lipidation→Alzheimer's Di50%

mentions📖APOE Lipid Dysregulation Causal Chain in AD50%

mentions📖section-209-glp-1-receptor-agonists-cbs-psp50%

mentions📖Astrocyte-Neuron Metabolic Coupling Pathway50%

mentions📖APOE-Expressing Astrocytes50%

mentions📖crispr-gene-editing50%

mentions📖Cerebral Amyloid Angiopathy (CAA)50%

mentions📖amyloid-pathology50%

mentions📖ALA-enriched Nutrition for APOE4 Carriers with MCI (NCT0739250%

mentions📖Metabolic-Epigenetic Axis in Neurodegeneration Synthesis50%

mentions📖Galectin-3 Inhibitor Therapy50%

mentions📖adpd-2026-precision-medicine-genetic-stratification50%

mentions📖Etalanetug (E2814)50%

mentions📖mTOR Inhibitors for Neurodegeneration50%

mentions📖AD Research Funding vs Evidence Alignment50%

mentions📖ADRD Biomarker Heterogeneity Framework50%

mentions📖Blood-Brain Barrier Breakdown in Alzheimer's Disease50%

mentions📖microglial-synaptic-pruning-dysregulation50%

mentions📖Tau Kinase Inhibitors50%

mentions📖sglt2-inhibitors-neurodegeneration44%

mentions📖Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP44%

mentions📖Proteostasis Therapeutics: Investment Landscape Analysis44%

mentions📖ER-Mitochondria Contact Sites (MAMs) in Neurodegeneration44%

mentions📖TREM2 Modulator Therapy44%

mentions📖Synaptic Boutons44%

mentions📖Adult Neurogenesis in Neurodegenerative Disease44%

mentions📖Alzheimer's Disease44%

mentions📖Neurovascular-Gut-Brain Axis in Neurodegeneration Synthesis44%

mentions📖Energy Metabolism Dysfunction Comparison Across Neurodegener44%

mentions📖TREM2 Mechanism Hub44%

mentions📖Precision Medicine in Neurodegeneration44%

mentions📖Simufilam (Aβ Oligomer Antagonist) Therapy44%

mentions📖Lipid Peroxidation in Neurodegeneration44%

mentions📖Microglia Dysfunction: AD vs PD vs ALS vs FTD vs HD Comparis44%

mentions📖ExPlas — Exercise Plasma Transfusion for Alzheimer's Di44%

mentions📖autophagy-lysosome-dysfunction44%

mentions📖SPAM1: SIRT6 Positive Allosteric Modulator44%

mentions📖AAV Gene Therapy for Neurodegeneration — Investment Landscap44%

mentions📖Section 152: Advanced Robotics and Assistive Devices in CBS/44%

mentions📖LRP1-Mediated Amyloid-Beta Clearance in Neurodegeneration44%

mentions📖Glymphatic System and Aβ Clearance in Alzheimer's Disea44%

mentions📖Entorhinal Cortex Layer III44%

mentions📖Entorhinal Cortex Layer II Neurons in Alzheimer's Disea44%

mentions📖Mechanism Rankings44%

mentions📖Gene Therapy for Neurodegenerative Diseases44%

mentions📖Section 147: Telehealth and Remote Monitoring in CBS/PSP44%

mentions📖GPNMB Modulation for Lipid-Laden Microglia Rescue44%

mentions📖LRRK2 Kinase-Targeting Therapies44%

mentions📖staree-statin-dementia-prevention44%

mentions📖Tauopathies Comparison Matrix44%

mentions📖CRISPR/Cas9 Gene Therapy for Neurodegeneration44%

mentions📖Cognitive Training to Reduce Incidence of Cognitive Impairme44%

mentions📖Gene Therapy for Neurodegenerative Diseases44%

mentions📖Gantenerumab44%

mentions📖Molecular Chaperone Therapy44%

mentions📖Apolipoprotein and Lipid Transport Therapy Landscape44%

mentions📖asm-inhibitors-small-biotech44%

mentions📖Lipid Peroxidation in Neurodegeneration44%

mentions📖Locus Coeruleus Degeneration in Alzheimer's Disease44%

mentions📖Microglial Priming Pathway in Neurodegeneration44%

mentions📖Brain Organoids44%

mentions📖Remternetug44%

mentions📖Cognitive Reserve Mechanisms in Alzheimer's Disease — M44%

mentions📖Section 193 Advanced Integrated Cell Stress Response Therapy44%

mentions📖amyloid-hypothesis44%

mentions📖Cerebrotendinous Xanthomatosis (CTX)44%

mentions📖Neuroprotective Peptides for Neurodegenerative Diseases44%

mentions📖SOD1-Targeting Therapies for ALS44%

mentions📖Ipamorelin — Selective Growth Hormone Secretagogue44%

mentions📖CRISPR Gene Editing for Parkinson's Disease44%

mentions📖Amyloid-Beta Aggregation and Plaque Formation44%

mentions📖DBS Nucleus Basalis Trial (NCT07218081): Deep Brain Stimulat44%

mentions📖Therapeutic Antibody Comparison Matrix44%

mentions📖Blood-Brain Barrier Biology and Crossing Strategies44%

mentions📖Antisense Oligonucleotide Therapy for Neurodegeneration44%

mentions📖Retinoid Pathway Modulator Therapy for Neurodegenerative Dis44%

mentions📖Microglia and neuroinflammation in Alzheimer's Disease44%

mentions📖Section 102: Proteostasis Network Dysregulation in CBS/PSP44%

mentions📖Section 188: Advanced Lipidomics and Membrane Therapy in CBS44%

mentions📖Investment Landscape44%

mentions📖donepezil44%

mentions📖Long-Term Potentiation Impairment in Neurodegeneration44%

mentions📖Liposome and Lipid-Based Brain Delivery44%

mentions📖Hypotheses44%

mentions📖Novartis Alzheimer's Disease Phase 2 Trial (NCT0709451644%

mentions📖Prion Strain Diversity and Selective Vulnerability44%

mentions📖cortisol-tau-pathway44%

mentions📖Alzheimer's Disease vs Parkinson's Disease Compari44%

mentions📖Neuroinflammation in Parkinson's Disease44%

mentions📖Gamma-Secretase Modulators44%

mentions📖Alpha-Synuclein ESCRT-III Inhibition Mechanism44%

mentions📖Targeted Protein Degradation for Neurodegenerative Diseases44%

mentions📖Autophagy-Lysosomal Impairment Comparison — AD/PD/ALS/FTD/HD44%

mentions📖Locus Coeruleus Degeneration Hypothesis in Alzheimer's 44%

mentions📖Ubiquitin Signatures on Aggregating Proteins44%

mentions📖Tau Immunotherapy44%

mentions📖Targeted Protein Degradation (PROTACs)44%

mentions📖protective-strategies-cbs-psp44%

mentions📖Phage Display and Directed Evolution for Tau Therapeutics44%

mentions📖Neuroimmune Genes in Alzheimer's Disease — TREM2, CD33,44%

mentions📖LRRK2-Targeting Therapies44%

mentions📖Transdiagnostic Proteomic Changes in Neurodegeneration44%

mentions📖CBS Frontal Cortical Involvement44%

mentions📖Amyloid-beta Oligomerization Pathway44%

mentions📖Brain Insulin Signaling Pathway44%

mentions📖Non-Pharmacological Interventions for Behavioral Symptoms44%

mentions📖Autophagy-Lysosomal Dysfunction in Neurodegenerative Disease44%

mentions📖Traumatic Brain Injury and Alzheimer's Disease Relation44%

mentions📖TREM2 Variants in Alzheimer's Disease44%

mentions📖Sleep and Circadian Dysfunction in Alzheimer's Disease44%

mentions📖Tau Small-Molecule Therapeutics44%

mentions📖AD Therapeutic Approaches Ranked Scorecard44%

mentions📖CRISPR-Cas9 Gene Editing for Neurodegenerative Diseases44%

mentions📖Tau Co-Pathology in DLB Clinical Heterogeneity44%

related📖SREBF1 Gene10%

related📖SCD1 Gene10%

Reference URLs

Canonical (singular)/artifact/experiment-exp-3b7faafc-4bd9-407f-ae87-8cfbd6237e51canonical

Canonical (plural, REST)/artifacts/experiment-exp-3b7faafc-4bd9-407f-ae87-8cfbd6237e51alias

Type prefix (singular)/experiment/experiment-exp-3b7faafc-4bd9-407f-ae87-8cfbd6237e51alias

Type prefix (plural)/experiments/experiment-exp-3b7faafc-4bd9-407f-ae87-8cfbd6237e51alias

API (JSON)/api/artifacts/experiment-exp-3b7faafc-4bd9-407f-ae87-8cfbd6237e51api

Citation — BibTeX/artifacts/experiment-exp-3b7faafc-4bd9-407f-ae87-8cfbd6237e51/cite?fmt=bibtexexport

Citation — RIS/artifacts/experiment-exp-3b7faafc-4bd9-407f-ae87-8cfbd6237e51/cite?fmt=risexport

Citation — CSL-JSON/artifacts/experiment-exp-3b7faafc-4bd9-407f-ae87-8cfbd6237e51/cite?fmt=cslexport

Embed this artifact

Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.

HTML iframe

<iframe src="http://scidex.ai/artifact/experiment-exp-3b7faafc-4bd9-407f-ae87-8cfbd6237e51?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>

Markdown link

[Multi-omics analysis of myricanol effects on gene expression and microRNA regulation](http://scidex.ai/artifact/experiment-exp-3b7faafc-4bd9-407f-ae87-8cfbd6237e51)

Direct URL

http://scidex.ai/artifact/experiment-exp-3b7faafc-4bd9-407f-ae87-8cfbd6237e51

Preview

🔄 Adjacent Artifacts Recommended based on your interests

💬 Discussion

Loading comments...

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.